• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用微流控装置研究时间和剂量变化对单个白血病细胞对肽酶抑制剂治疗的反应。

Response of single leukemic cells to peptidase inhibitor therapy across time and dose using a microfluidic device.

机构信息

Department of Chemistry, CB 3290, University of North Carolina, Chapel Hill, NC 27599, USA.

出版信息

Integr Biol (Camb). 2014 Feb;6(2):164-74. doi: 10.1039/c3ib40249e.

DOI:10.1039/c3ib40249e
PMID:24413844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3940261/
Abstract

Single-cell methodologies are revealing cellular heterogeneity in numerous biological processes and pathologies. For example, cancer cells are characterized by substantial heterogeneity in basal signaling and in response to perturbations, such as drug treatment. In this work, we examined the response of 678 individual U937 (human acute myeloid leukemia) cells to an aminopeptidase-inhibiting chemotherapeutic drug (Tosedostat) over the course of 95 days. Using a fluorescent reporter peptide and a microfluidic device, we quantified the rate of reporter degradation as a function of dose. While the single-cell measurements reflected ensemble results, they added a layer of detail by revealing unique degradation patterns and outliers within the larger population. Regression modeling of the data allowed us to quantitatively explore the relationships between reporter loading, incubation time, and drug dose on peptidase activity in individual cells. Incubation time was negatively correlated with the number of peptide fragment peaks observed, while peak area (which was proportional to reporter loading) was positively correlated with both the number of fragment peaks observed and the degradation rate. Notably, a statistically significant change in the number of peaks observed was identified as dose increased from 2 to 4 μM. Similarly, a significant difference in degradation rate as a function of reporter loading was observed for doses ≥2 μM compared to the 1 μM dose. These results suggest that additional enzymes may become inhibited at doses >1 μM and >2 μM, demonstrating the utility of single-cell data to yield novel biological hypotheses.

摘要

单细胞方法正在揭示许多生物学过程和病理学中的细胞异质性。例如,癌细胞在基础信号和对药物治疗等干扰的反应方面存在很大的异质性。在这项工作中,我们在 95 天的时间内研究了 678 个单独的 U937(人急性髓系白血病)细胞对一种氨肽酶抑制化疗药物(Tosedostat)的反应。使用荧光报告肽和微流控设备,我们定量测量了报告物降解的速度作为剂量的函数。虽然单细胞测量反映了总体结果,但它们通过揭示较大群体中的独特降解模式和异常值,增加了一层细节。对数据的回归建模使我们能够定量探索报告物负载、孵育时间和药物剂量与单个细胞中肽酶活性之间的关系。孵育时间与观察到的肽片段峰的数量呈负相关,而峰面积(与报告物负载成正比)与观察到的片段峰的数量和降解速率呈正相关。值得注意的是,当剂量从 2 到 4 μM 增加时,观察到的峰数的统计学显著变化被识别出来。同样,与 1 μM 剂量相比,在 2 μM 以上剂量下观察到的降解速率存在显著差异。这些结果表明,在剂量大于 1 μM 和大于 2 μM 时,可能会有更多的酶被抑制,这表明单细胞数据可以产生新的生物学假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3940261/4e5aee488802/nihms557501f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3940261/07804cab4383/nihms557501f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3940261/9049ab4000be/nihms557501f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3940261/c3e1681b7a7e/nihms557501f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3940261/9b0f005033ff/nihms557501f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3940261/f2b55bc2882f/nihms557501f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3940261/4e5aee488802/nihms557501f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3940261/07804cab4383/nihms557501f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3940261/9049ab4000be/nihms557501f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3940261/c3e1681b7a7e/nihms557501f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3940261/9b0f005033ff/nihms557501f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3940261/f2b55bc2882f/nihms557501f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3940261/4e5aee488802/nihms557501f6.jpg

相似文献

1
Response of single leukemic cells to peptidase inhibitor therapy across time and dose using a microfluidic device.利用微流控装置研究时间和剂量变化对单个白血病细胞对肽酶抑制剂治疗的反应。
Integr Biol (Camb). 2014 Feb;6(2):164-74. doi: 10.1039/c3ib40249e.
2
Aminopeptidase inhibition by the novel agent CHR-2797 (tosedostat) for the therapy of acute myeloid leukemia.新型药物 CHR-2797(托塞达司特)通过抑制氨肽酶治疗急性髓系白血病。
Leuk Res. 2011 May;35(5):677-81. doi: 10.1016/j.leukres.2010.10.030. Epub 2010 Dec 9.
3
Microfluidic chemical cytometry of peptide degradation in single drug-treated acute myeloid leukemia cells.微流控化学细胞术分析单个药物处理的急性髓系白血病细胞中肽的降解。
Anal Chem. 2013 May 21;85(10):4991-7. doi: 10.1021/ac4002029. Epub 2013 May 2.
4
Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasia.Tosedostat 是一种氨肽酶抑制剂的 I/II 期临床研究,用于治疗急性髓系白血病和骨髓增生异常综合征患者。
J Clin Oncol. 2010 Oct 1;28(28):4333-8. doi: 10.1200/JCO.2009.27.6295. Epub 2010 Aug 23.
5
Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study.两种剂量的托塞达司特在老年复发/难治性急性髓系白血病患者中的应用(OPAL):一项随机、开放标签的 2 期研究。
Lancet Oncol. 2013 Apr;14(4):354-62. doi: 10.1016/S1470-2045(13)70037-8. Epub 2013 Feb 28.
6
Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS.托西司他联合阿糖胞苷或地西他滨用于新诊断的老年急性髓系白血病或高危骨髓增生异常综合征患者的II期研究。
Br J Haematol. 2016 Jan;172(2):238-45. doi: 10.1111/bjh.13829. Epub 2015 Nov 16.
7
Discovery of Anticancer Clinical Candidate, Tosedostat, As an Analgesic Agent.发现抗癌临床候选药物托塞司他作为一种镇痛剂。
ACS Chem Neurosci. 2019 Sep 18;10(9):4007-4017. doi: 10.1021/acschemneuro.9b00230. Epub 2019 Aug 28.
8
A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumours.一项 Ib 期剂量递增研究,旨在评估在晚期实体瘤患者中添加氨肽酶抑制剂托塞达司特(CHR-2797)联合紫杉醇的安全性和耐受性。
Br J Cancer. 2010 Oct 26;103(9):1362-8. doi: 10.1038/sj.bjc.6605917. Epub 2010 Sep 28.
9
CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells.CHR - 2797:一种抗增殖氨肽酶抑制剂,可导致人白血病细胞中的氨基酸剥夺。
Cancer Res. 2008 Aug 15;68(16):6669-79. doi: 10.1158/0008-5472.CAN-07-6627.
10
Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.介电泳微流控芯片可用于对异质性急性髓系白血病患者样本中的多药耐药进行单细胞测量。
Anal Chem. 2016 Jun 7;88(11):5680-8. doi: 10.1021/acs.analchem.5b04446. Epub 2016 May 17.

引用本文的文献

1
Chemical fixation to arrest phospholipid signaling for chemical cytometry.用于化学细胞计数法的化学固定以阻止磷脂信号传导
J Chromatogr A. 2017 Nov 10;1523:97-106. doi: 10.1016/j.chroma.2017.05.022. Epub 2017 May 10.
2
Rational Design of a Dephosphorylation-Resistant Reporter Enables Single-Cell Measurement of Tyrosine Kinase Activity.抗去磷酸化报告基因的合理设计实现了酪氨酸激酶活性的单细胞测量。
ACS Chem Biol. 2016 Feb 19;11(2):355-62. doi: 10.1021/acschembio.5b00667. Epub 2015 Dec 4.
3
Pronase E-Based Generation of Fluorescent Peptide Fragments: Tracking Intracellular Peptide Fate in Single Cells.基于链霉蛋白酶E生成荧光肽片段:追踪单细胞内肽的命运
Anal Chem. 2015 Aug 4;87(15):7987-95. doi: 10.1021/acs.analchem.5b01929. Epub 2015 Jul 24.

本文引用的文献

1
Drug treatment of cancer cell lines: a way to select for cancer stem cells?癌细胞系的药物治疗:选择癌症干细胞的一种方法?
Cancers (Basel). 2011 Mar 4;3(1):1111-28. doi: 10.3390/cancers3011111.
2
An integrated microfluidic device for monitoring changes in nitric oxide production in single T-lymphocyte (Jurkat) cells.一种用于监测单个 T 淋巴细胞(Jurkat)细胞中一氧化氮产生变化的集成微流控装置。
Anal Chem. 2013 Nov 5;85(21):10188-95. doi: 10.1021/ac401665u. Epub 2013 Oct 7.
3
Measurement of protein tyrosine phosphatase activity in single cells by capillary electrophoresis.采用毛细管电泳法测定单细胞中的蛋白酪氨酸磷酸酶活性。
Anal Chem. 2013 Jun 18;85(12):6136-42. doi: 10.1021/ac401106e. Epub 2013 May 30.
4
Microfluidic chemical cytometry of peptide degradation in single drug-treated acute myeloid leukemia cells.微流控化学细胞术分析单个药物处理的急性髓系白血病细胞中肽的降解。
Anal Chem. 2013 May 21;85(10):4991-7. doi: 10.1021/ac4002029. Epub 2013 May 2.
5
Automated capillary electrophoresis system for fast single-cell analysis.自动化毛细管电泳系统,用于快速单细胞分析。
Anal Chem. 2013 May 7;85(9):4797-804. doi: 10.1021/ac4005887. Epub 2013 Apr 9.
6
Development of a peptidase-resistant substrate for single-cell measurement of protein kinase B activation.开发一种对肽酶有抗性的底物,用于单个细胞中蛋白激酶 B 激活的测量。
Anal Chem. 2012 Aug 21;84(16):7195-202. doi: 10.1021/ac301489d. Epub 2012 Aug 9.
7
Metabolism of peptide reporters in cell lysates and single cells.肽报告物在细胞裂解物和单细胞中的代谢。
Analyst. 2012 Jul 7;137(13):3028-38. doi: 10.1039/c2an16162a. Epub 2012 Feb 7.
8
Clonal evolution in cancer.癌症中的克隆进化。
Nature. 2012 Jan 18;481(7381):306-13. doi: 10.1038/nature10762.
9
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.全基因组测序揭示复发急性髓系白血病的克隆进化。
Nature. 2012 Jan 11;481(7382):506-10. doi: 10.1038/nature10738.
10
Sample transport and electrokinetic injection in a microchip device for chemical cytometry.用于化学细胞术的微芯片装置中的样品输送和电动进样。
Electrophoresis. 2011 Nov;32(22):3180-7. doi: 10.1002/elps.201100234. Epub 2011 Oct 20.